Lupin & SteinCares Biosimilar Deal

  Published 10 months ago

Lupin partnered with SteinCares to commercialize its ranibizumab biosimilar throughout Latin America (excluding Mexico & Argentina). SteinCares will manage regulatory & commercial aspects, while Lupin handles manufacturing.

  • SteinCares leads LATAM commercialization.
  • Lupin manufactures ranibizumab.
  • Ranibizumab treats various retinal conditions.

You might like these

PTC wins key turbine blade order

Cupid Limited FY25: Mixed Results & Future Outlook

Marico Eyes Modest Q1 FY26 Profit Growth

HDFC Bank Reports Steady Q1 Growth

Chandan Verma Appointed CFO at HSRC Infra Services

Page Industries Hits 3-Month Low

Modi Launches Maruti e‑Vitara, EV Hub

News that matters the most ⚡